NCT05012410Completed
WeCareAdvisor Study for Caregivers of People Living With Dementia
Efficacy of the WeCareAdvisor: An Online Tool to Help Caregivers Manage Behavioral and Psychological Symptoms in Persons Living With Dementia
Source: ClinicalTrials.gov · Last updated 30 Sept 2025
Brief summary (registry, in English)
The WeCareAdvisor is an online tool to help caregivers manage behavioral and psychological symptoms of people living with dementia. The trial will evaluate its efficacy to reduce caregiver distress, improve confidence managing behaviors, as well as reduce occurrences and severity of behavioral and psychological symptoms. Visit https://wecareadvisorstudy.com/ for more information.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 262 (actual)
- First submitted
- 6 Aug 2021
- Start date
- 13 Dec 2021
- Primary completion date
- 19 Jul 2024
- Lead sponsor
- Drexel University
- NCT number
- NCT05012410
What you commit to
- Study type: Interventional
- Participants enrolled: 262
- From 13 Dec 2021 to the primary completion date, 19 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Caregiver currently involved in another clinical trial of psychosocial or educational interventions for dementia;
- Caregiver has a visual impairment that prohibits interaction with the tool, and/or have a hearing impairment sufficient to prohibit telephone communication;
- Caregiver reports person living with dementia is not responsive to his/her environment (e.g., unable to understand short commands or recognize a person coming in/out of the room);
- Caregiver reports person living with dementia is an active suicide risk
- Caregiver reports person living with dementia is likely to have an imminent placement in a long-term care facility (within 6 months).
- Either caregiver/person living with dementia has a terminal disease with life expectancy \< 6 months, is in active treatment for cancer, or has had more than 3 acute medical hospitalizations over the past year.
Who the study is looking for
- self-identify as the primary caregiver to the person living with memory loss or dementia;
- has been a primary caregiver for at least 6 months;
- report managing \>1 behavioral symptom(s) in the past month;
- has an email account or smartphone (to receive daily tips and reminder messages);
- English speaking;
- has own smartphone, tablet, laptop, or desktop computer and access to Internet;
- If person living with dementia is on an anti-dementia or psychotropic medication, they must be on a stable dose for at least 60 days prior to enrollment.
- If caregiver is on an anti-depression or other psychotropic medication, they must be on a stable does for at least 60 days prior to enrollment
- Lives in the United States or US territory
Age in the registry: 21 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Drexel University Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.